8.1.3 Antimetabolites

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

291 library items in 8.1.3 Antimetabolites

Filter results by:

Date Published

NeLM Area

News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies

Results filtered by:

Category

8: Malignant disease and immunosuppression (remove) , 8.1 Cytotoxic drugs (remove) , 8.1.3 Antimetabolites (remove)

Sort by: Display summary:

Results 1 - 10 of 291

Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next

1.

Horizon scanning: Glucarpidase (Voraxaze®) launched in US for treatment of toxic plasma levels of methotrexate

Source: BioSpace ,
Date published: 01/05/2012

Category:

8.1.3 Antimetabolites | Adverse Drug Reactions | Food &Drug Administration (FDA) | New drugs | Oncology | Renal medicine

NeLM Area:

News

Link
2.

Long-term outcomes from the CAO/ARO/AIO-94 shows no difference in overall survival following preoperative vs. postoperative chemoradiotherapy in advanced rectal cancer

Source: Journal of Clinical Oncology,
Date published: 30/04/2012

Category:

8.1.3 Antimetabolites | Cancer: gastroenterological

NeLM Area:

News

Abstract
3.

RCT: Chemotherapy with or without bevacizumab in platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer

Source: JCO,
Date published: 24/04/2012

Category:

8.1.3 Antimetabolites | 8.1.5 Other antineoplastic drugs | Obstetrics &Gynaecology

NeLM Area:

News

Abstract
4.

RCT: Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer

Source: N Engl J Med,
Date published: 19/04/2012

Category:

8.1.2 Anthracyclines and other cytotoxic antibiotics | 8.1.3 Antimetabolites | Cancer: bladder

NeLM Area:

News

Abstract

Editorial- full text access for subscribers only
5.

Phase III study shows cladribine added to daunorubicin and cytarabine during induction results in improved survival in AML patients

Source: JCO,
Date published: 17/04/2012

Category:

8.1.3 Antimetabolites | Leukaemia

NeLM Area:

News

Abstract
6.

Counselling on the use of capecitabine

Source: Pharmaceutical Journal,
Date published: 17/04/2012

Category:

8.1.3 Antimetabolites | Hospital pharmacy | Patient

NeLM Area:

Evidence > Medicines Management > References

PJ Online website
7.

Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer

Source: Lancet,
Date published: 13/04/2012

Category:

8.1.3 Antimetabolites | Cancer: gastroenterological

NeLM Area:

News

Link (abstract)
8.

Pemetrexed in combination with cisplatin versus cisplatin monotherapy confers no significant survival benefit in patients with recurrent or metastatic head and neck cancer: RCT

Source: Cancer,
Date published: 12/04/2012

Category:

8.1.3 Antimetabolites | 8.1.5 Other antineoplastic drugs | Cancer: other

NeLM Area:

News

Abstract
9.

London Cancer New Drugs Group Rapid Review: Oxaliplatin and fluorouracil for second line treatment of advanced pancreatic cancer

Source: London Cancer New Drugs Group,
Date published: 12/04/2012

Category:

8.1.3 Antimetabolites | 8.1.5 Other antineoplastic drugs | Cancer: pancreas | Drug reviews

NeLM Area:

Evidence > Drug Specific Reviews

Oxaliplatin_and_fluorouracil for_second_line_treatment
10.

Vidaza 25mg/ml powder for suspension (azacitidine) Revised SPC

Source: eMC (electronic Medicines Compendium),
Date published: 08/03/2012

Category:

8.1.3 Antimetabolites | Multiple myeloma | Product Licence Changes

NeLM Area:

Other Library Updates > SPC Changes

SPC

Results 1 - 10 of 291

Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next